Search Results
Results found for "GPCR research community"
- Dr. Maria Majellaro perfected her focaccia recipe. Then, with Celtarys, the team did the same for ligand-linker-fluorophore chemistry. It’s not just culinary precision, it’s a metaphor for drug discovery done right. In Ep. 168, she shares how Celtarys went from a thesis idea to a biotech reality. Meet Dr.GPCR’s new partner: Celtarys 🙌 👉 See what they’re cooking up now: Ep 168 with Dr. Maria Majellaro from Celtarys #GPCRresearchCommunity #DrGPCR #StartupScience #BiotechFounders #GPCRscientistNetwork | Dr. GPCR Ecosystem
GPCR Podcast Dr. Maria Majellaro perfected her focaccia recipe.
- error | Dr. GPCR Ecosystem
Awkward... This page isn’t available. Go Home
- error | Dr. GPCR Ecosystem
Awkward... This page isn’t available. Go Home
- 500 | Dr. GPCR Ecosystem
Time Out This page isn’t available right now. But we’re working on a fix, ASAP. Try again soon. Go Back
- 500 | Dr. GPCR Ecosystem
Time Out This page isn’t available right now. But we’re working on a fix, ASAP. Try again soon. Go Back
- Dr. GPCR University CheatSheet | Dr. GPCR Ecosystem
GPCR University CheatSheet! Filter by topics and access exclusive content for premium members. 🔍 Search Filter by topics and events to find what you need 🔐 Access Exclusive content only available
- The Practical Assessment of Signaling Bias | Dr. GPCR Ecosystem
that bias is not an exception but a fundamental principle of pharmacology, occurring whether or not researchers bias and compare drug efficacy more precisely. 💊 Therapeutic Potential : Understanding bias enables researchers 🔹 Instead of avoiding bias, researchers can embrace it to refine drug responses. Dr. navigate this crucial gap. 📌 The Future of Drug Development 🚀 🔹 By integrating bias into drug design , researchers Whether you're a researcher, student, or industry professional, this session is packed with insights
- Unlock your pharmacology potential with Terry’s Corner. No fluff. Just clear, on-demand insight from Dr. Terry Kenakin—built for scientists at every level. 🟢 Building core expertise? Learn dose-response, agonism, binding, bias, kinetics, and the models that build real confidence. 🟢 Driving drug discovery? Apply pharmacology to selectivity, ADME, early safety, and smarter decision-making. 🟢 Already a drug hunter? Sharpen your edge with allosteric modulation, residence time, molecular dynamics, and translational PK/PD. Learn on-demand. Apply immediately. Early access begins July 1 → https://www.terrykenakin.com #pharmacology #GPCRscience #drugdiscovery #TerrysCorner #biotechtraining | Dr. GPCR Ecosystem
Home → Flash News → Unlock your pharmacology potential with Terry’s Corner. No fluff. Just clear, on-demand insight from Dr. Terry Kenakin—built for scientists at every level. 🟢 Building core expertise? Learn dose-response, agonism, binding, bias, kinetics, and the models that build real confidence. 🟢 Driving drug discovery? Apply pharmacology to selectivity, ADME, early safety, and smarter decision-making. 🟢 Already a drug hunter? Sharpen your edge with allosteric modulation, residence time, molecular dynamics, and translational PK/PD. Learn on-demand. Apply immediately. Early access begins July 1 → https://www.terrykenakin.com #pharmacology #GPCRscience #drugdiscovery #TerrysCorner #biotechtraining Published on June 28, 2025 Category Terry's Corner Unlock your pharmacology potential with Terry’s Corner. No fluff. Just clear, on-demand insight from Dr. Terry Kenakin—built for scientists at every level. 🟢 Building core expertise? Learn dose-response, agonism, binding, bias, kinetics, and the models that build real confidence. 🟢 Driving drug discovery? Apply pharmacology to selectivity, ADME, early safety, and smarter decision-making. 🟢 Already a drug hunter? Sharpen your edge with allosteric modulation, residence time, molecular dynamics, and translational PK/PD. Learn on-demand. Apply immediately. Early access begins July 1 → https://www.terrykenakin.com #pharmacology #GPCRscience #drugdiscovery #TerrysCorner #biotechtraining Recent Articles Previous Next
